0
About Search
About the Cover
RSSRSS   Get Alerts
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue

July-August 2012

| Vol. 52. No. 4
  |  

Journal of the American Pharmacists Association

Special Feature

Improving care transitions: Optimizing medication reconciliation
American Pharmacists Association and American Society of Health-System Pharmacists
J Am Pharm Assoc. 2012;52:e43-e52.   doi: 10.1331/JAPhA.2012.12527

Objective  To improve understanding of the medication reconciliation process, its effect on patient care and outcomes, and how pharmacists can ...

[Continue Reading]
Tags: health personnel, medication reconciliation

Research

Determining predictors of response to exenatide in type 2 diabetes
Sarah L. Anderson, PharmD, BCPS; Jennifer M. Trujillo, PharmD, BCPS, CDE; Michael McDermott, MD; et al.
J Am Pharm Assoc. 2012;52:466-471.   doi: 10.1331/JAPhA.2012.10217

Objectives  To determine predictors of glycemic response to exenatide and to assess change in glycosylated hemoglobin (A1C) and whether a ...

[Continue Reading]
Tags: diabetes mellitus, type 2, exenatide
Pharmacy staff characteristics associated with support for pharmacy-based HIV testing
Silvia Amesty, MD, MPH, MSEd; Shannon Blaney, MPH; Natalie D. Crawford, PhD; et al.
J Am Pharm Assoc. 2012;52:472-479.   doi: 10.1331/JAPhA.2012.10194

Objectives  To determine support of in-pharmacy human immunodeficiency virus (HIV) testing among pharmacy staff and the individual-level characteristics associated with ...

[Continue Reading]
Tags: hiv screen
Recovering substance-impaired pharmacists' views regarding occupational risks for addiction
Lisa J. Merlo, PhD, MPE; Simone M. Cummings, PhD; Linda B. Cottler, PhD, MPH; et al.
J Am Pharm Assoc. 2012;52:480-491.   doi: 10.1331/JAPhA.2012.10214

Objective  To better understand the occupational risks for substance use disorders among pharmacists and possibilities for improved prevention.

Design  Descriptive, ...

[Continue Reading]
Tags: addictive behavior, prescriptions, drug, substance use disorders
Point-of-care screening to identify cognitive impairment in older adults
Travis E. Sonnett, PharmD; Stephen M. Setter, PharmD, CGP, CDE, FASCP; Douglas L. Weeks, PhD; et al.
J Am Pharm Assoc. 2012;52:492-497.   doi: 10.1331/JAPhA.2012.11012

Objective  To explore associations between results of a rapid screening tool for cognitive impairment and individual patient characteristics in a ...

[Continue Reading]
Tags: dementia, cognitive impairment, screening, elderly
Quality-related event learning in community pharmacies: Manual versus computerized reporting processes
Todd A. Boyle, PhD; Andrea C. Scobie, MHSA, PhD; Neil J. MacKinnon, PhD; et al.
J Am Pharm Assoc. 2012;52:498-506.   doi: 10.1331/JAPhA.2012.11004

Objective  To determine how staff assessment of key quality-related event (QRE) reporting process characteristics (e.g., ease of use, time to ...

[Continue Reading]
Tags: community pharmacies
Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies
Pallavi D. Patwardhan, PhD, BSPharm; Betty A. Chewning, PhD
J Am Pharm Assoc. 2012;52:507-514.   doi: 10.1331/JAPhA.2012.10117

Objectives  To test the feasibility of implementing ask–advise–refer (AAR) tobacco cessation counseling approach in community chain pharmacies serving low socioeconomic ...

[Continue Reading]
Tags: patient referral, smoking cessation, counseling, intervention studies, tobacco, chain community pharmacy

Research Notes

Pharmaceutical care program for elderly patients with uncontrolled hypertension
Patricia M. Aguiar, MS; Blicie J. Balisa-Rocha, MS; Giselle C. Brito; et al.
J Am Pharm Assoc. 2012;52:515-518.   doi: 10.1331/JAPhA.2012.11015

Objective  To evaluate the effect of a pilot pharmaceutical care program developed for elderly patients with uncontrolled hypertension.

Methods  Nonrandomized ...

[Continue Reading]
Tags: hypertension, blood pressure, elderly, pharmaceutical care
Evaluation of outcomes of a medication therapy management program for patients with diabetes
Sharrel L. Pinto, PhD; Robert A. Bechtol, MS; Gautam Partha, BSPharm; et al.
J Am Pharm Assoc. 2012;52:519-523.   doi: 10.1331/JAPhA.2012.10098

Objective  To measure the impact of an employer-sponsored, pharmacist-provided medication therapy management (MTM) program on clinical outcomes and social and ...

[Continue Reading]
Tags: diabetes mellitus, type 2, medication therapy management
Evaluation of pharmacy practice residents' research abstracts and publication rate
Kate M. O'Dell, PharmD, BCPS; Sachin A. Shah, PharmD
J Am Pharm Assoc. 2012;52:524-527.   doi: 10.1331/JAPhA.2012.10224

Objective  To determine the type, scope, and publication rate of pharmacy practice residency projects conducted in a subgroup of the ...

[Continue Reading]
Tags: medical residencies

Reviews

Treatment of infertility in women
Carriann Smith, PharmD; Maureen Grimm, PharmD; Megan Schwegel; et al.
J Am Pharm Assoc. 2012;52:e27-e42.   doi: 10.1331/JAPhA.2012.12044

Objectives  To review causes and risk factors associated with infertility, relevant diagnostic procedures, and available pharmacologic and nonpharmacologic treatment options; ...

[Continue Reading]
Tags: female infertility, infertility, women

Experience

Assessing quality in pharmacy education in an era of rapid expansion
Lucinda L. Maine, PhD; Peter H. Vlasses, PharmD, DSc (Hon), BCPS, FCCP
J Am Pharm Assoc. 2012;52:528-534.   doi: 10.1331/JAPhA.2012.11229

Objectives  To describe measures used to evaluate the quality of U.S. pharmacy graduates in an era of rapid increases in ...

[Continue Reading]
Tags: education, pharmacy, accreditation council for pharmacy education
Efficacy of an over-the-counter intervention follow-up program in community pharmacies
Nicole Bosse, PharmD; Matthew Machado, PharmD; Amee Mistry, PharmD; et al.
J Am Pharm Assoc. 2012;52:535-540.   doi: 10.1331/JAPhA.2012.10093

Objective  To evaluate whether patient adherence to appropriate self-care advice from a pharmacist or professional year 4 (PY4) advanced pharmacy ...

[Continue Reading]
Tags: drugs, non-prescription, telephone, community pharmacies

Features

2012 Presidential Address: Transforming patient care by LEADing
The tipping point: It's here!
Jenelle L. Sobotka, PharmD, FAPhA
J Am Pharm Assoc. 2012;52:446-449.   doi: 10.1331/JAPhA.2012.12521
Good morning! I am delighted to be here and excited to serve as our Association's next president. [Continue Reading]
Tags: health personnel, perception, health care systems, advocacy
2012 Remington Lecture: Culture trumps strategy
We must encourage the next generation of pharmacists to keep looking over the horizon and not be limited by what they can see today
William E. Evans
J Am Pharm Assoc. 2012;52:450-453.   doi: 10.1331/JAPhA.2012.12522
Let me begin by saying how honored and humbled I am to be the 2012 recipient of the APhA Remington Honor Medal. ... [Continue Reading]
Tags: pharmacotherapy, diphenhydramine, acute lymphocytic leukemia, antineoplastic agents, cancer, awards and prizes, institute ...
2012 Prescott Lecture: The nonpharmacologic basis of therapeutics
To get to the next level in interprofessional patient care, pharmacists need to recognize the social and interpersonal aspects of medical decision making
Conan MacDougall
J Am Pharm Assoc. 2012;52:454-456.   doi: 10.1331/JAPhA.2012.12523
I'd like to start off by saying I'm very honored to receive the Albert B. Prescott award for this year. To be ... [Continue Reading]
Tags: decision making
Report of the 2012 APhA House of Delegates
Actions of the legislative body of the American Pharmacist Association
J Am Pharm Assoc. 2012;52:457-460.   doi: 10.1331/JAPhA.2012.12524
The following policies were adopted by the 2012 APhA House of Delegates and are now official Association policy: [Continue Reading]
Tags: employment, health personnel, product packaging, safety, students, pharmacy, economics, controlled substance, pharmaceutical ...
2012 APhA awards and honors
The profession honors distinguished practitioners, scientists, and student pharmacists
J Am Pharm Assoc. 2012;52:461-464.   doi: 10.1331/JAPhA.2012.12525
Remington Honor Medal [Continue Reading]
Tags: awards and prizes
2011 APhA Treasurer's Report
Clark Gustafson, BSPharm
J Am Pharm Assoc. 2012;52:464-465.   doi: 10.1331/JAPhA.2012.12526
On behalf of the APhA Finance Committee, I am pleased to report that APhA posted its fifteenth consecutive annual operating surplus in ... [Continue Reading]
Tags: economics, finance

Association Report

APhA House of Delegates: Dauntlessly tackling difficult issues facing the profession
Amber L. Briggs, PharmD, BC-ADM, CGP, BCPS, FASCP; Mary McManus, PhD, BSPharm; Ashley E. Weems, PharmD; et al.
J Am Pharm Assoc. 2012;52:432-444.   doi: 10.1331/JAPhA.2012.12520
I have been a part of the APhA House of Delegates (HOD) since I was a resident in Illinois and currently serve ... [Continue Reading]
Tags: students, pharmacy, controlled substance, pharmacy benefits managers, medication shortages

Vaccine Update

Improving hepatitis B vaccination rates in the hemodialysis population
Katelyn R. Richards, PharmD; Mary S. Hayney, PharmD, MPH, FCCP, BCPS
J Am Pharm Assoc. 2012;52:542-544.   doi: 10.1331/JAPhA.2012.12528
More than 2 billion people worldwide are estimated to have been infected with hepatitis B virus (HBV), and of these, 360 million ... [Continue Reading]
Tags: hemodialysis, vaccination, hepatitis b vaccine

New Drugs

Clobazam, ezogabine, and tafluprost
Daniel A. Hussar, PhD; Sarah E. Hallinan, PharmD
J Am Pharm Assoc. 2012;52:546-550.   doi: 10.1331/JAPhA.2012.12529
Tags: anticonvulsants, epilepsy, ezogabine, tafluprost, clobazam

Science Snippets

APACHE II mortality prediction, health symptoms and disability, and pharmacists and diabetes management teams
L. Douglas Ried, PhD
J Am Pharm Assoc. 2012;52:552.   doi: 10.1331/JAPhA.2012.12530
Seven pharmacists were part of a team concluding that “the APACHE II score may be a valid tool to control for confounding ... [Continue Reading]
Tags: diabetes mellitus, type 2, apache ii score, mortality, disability
  |  
Abstract
close X
Advertisement
Copyright © American Pharmacists Association
All rights reserved.
Powered by: Silverchair Information / Systems
© 2011 Silverchair. All Rights Reserved.   ---